Onconetix(DE:J4T2)
€119,850.000.00 (0.00%)
DE:J4T2
Onconetix financials statements
€119,850.00
At close:0.00 (0.00%)
Onconetix (J4T2) Ratios
0 Followers
Onconetix Ratios
DE:J4T2's free cash flow for Q2 2026 was $-1.92M. For the 2026 fiscal year, DE:J4T2's free cash flow was increased by $0.00 and operating cash flow was $-1.92M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.66 | 0.05 | 0.34 | 6.69 | 1.88 |
| Quick Ratio | 0.65 | 0.05 | 0.32 | 6.69 | 1.88 |
| Cash Ratio | 0.57 | 0.04 | 0.26 | 6.57 | 1.18 |
| Solvency Ratio | -1.53 | -3.12 | -0.43 | -3.42 | -2.08 |
| Operating Cash Flow Ratio | -1.06 | -0.57 | -0.79 | -2.21 | -1.25 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -1.13 | -1.41 | 0.00 | 0.00 |
| Net Current Asset Value | $ -3.09M | $ -17.62M | $ -80.28M | $ 22.34M | $ 1.44M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.34 | 0.11 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.98 | -1.76 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.50 | 2.31 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.58 | 2.93 | -15.62 | 1.18 | 2.13 |
| Debt Service Coverage Ratio | -17.66 | -5.27 | -3.57 | 0.00 | 0.00 |
| Interest Coverage Ratio | -8.45 | -40.13 | -53.65 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.03 | 2.87 | 0.00 | 0.00 |
| Interest Debt Per Share | 2.44 | 96.02 | 2098.05 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.39 | -0.15 | -0.15 | 1.92 | 0.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 77.62% | 41.80% | -1927.93% | 0.00% | 0.00% |
| EBIT Margin | -1628.81% | -2310.85% | -62859.25% | 0.00% | 0.00% |
| EBITDA Margin | -1626.95% | -2281.88% | -62784.10% | 0.00% | 0.00% |
| Operating Profit Margin | -778.16% | -2237.96% | -61634.47% | 0.00% | 0.00% |
| Pretax Profit Margin | -1720.91% | -2366.62% | -64008.02% | 0.00% | 0.00% |
| Net Profit Margin | -1720.98% | -2325.21% | -63986.48% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | -1720.98% | -2325.21% | -63986.48% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 98.25% | 99.97% | 100.00% | 100.00% |
| EBT Per EBIT | 221.15% | 105.75% | 103.85% | 99.54% | 100.00% |
| Return on Assets (ROA) | -56.29% | -208.26% | -42.75% | -51.01% | -110.78% |
| Return on Equity (ROE) | -89.01% | -610.69% | 667.79% | -59.94% | -236.24% |
| Return on Capital Employed (ROCE) | -40.18% | -571.09% | -51.24% | -60.22% | -236.24% |
| Return on Invested Capital (ROIC) | -40.12% | -286.99% | -45.02% | -60.22% | -236.24% |
| Return on Tangible Assets | -220.02% | -5182.02% | -581.71% | -51.01% | -110.78% |
| Earnings Yield | -5.48% | -19.39% | -1104.33% | -99.42% | -0.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.75 | 26.21 | 0.39 | 0.00 | 0.00 |
| Payables Turnover | 0.10 | 0.39 | 0.22 | 0.00 | 0.01 |
| Inventory Turnover | 1.22 | 22.93 | 3.26 | 0.00 | 0.00 |
| Fixed Asset Turnover | 9.50 | 13.84 | 0.28 | 0.00 | 0.00 |
| Asset Turnover | 0.03 | 0.09 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | -0.08 | -0.18 | 0.01 | 0.00 | 0.00 |
| Cash Conversion Cycle | -3083.32 | -911.23 | -583.26 | -81049.03 | -43486.88 |
| Days of Sales Outstanding | 132.89 | 13.93 | 934.78 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 299.99 | 15.92 | 112.07 | 0.00 | 0.00 |
| Days of Payables Outstanding | 3516.20 | 941.08 | 1630.12 | 81049.03 | 43486.88 |
| Operating Cycle | 432.88 | 29.85 | 1046.85 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -29.49 | -92.84 | -2698.93 | -2403.86 | -629.19 |
| Free Cash Flow Per Share | -29.49 | -93.09 | -2709.87 | -2406.45 | -629.78 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -44.69 | -246.73 | -928.96 | -1062.49 |
| Capital Expenditure Coverage Ratio | 0.00 | -368.65 | -246.73 | -928.96 | -1062.49 |
| Operating Cash Flow Coverage Ratio | -198.43 | -1.11 | -1.37 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -11.87 | -4.16 | -232.29 | 0.00 | 0.00 |
| Free Cash Flow Yield | -3.78% | -3.48% | -402.54% | -64.34% | -0.32% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -16.49 | -5.14 | -0.09 | -1.01 | -185.55 |
| Price-to-Sales (P/S) Ratio | 313.95 | 119.92 | 57.94 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 16.24 | 31.50 | -0.60 | 0.60 | 438.33 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -26.45 | -28.76 | -0.25 | -1.55 | -309.89 |
| Price-to-Operating Cash Flow Ratio | -26.45 | -28.84 | -0.25 | -1.56 | -310.18 |
| Price-to-Earnings Growth (PEG) Ratio | 0.17 | -0.00 | -0.00 | -0.00 | -1.53 |
| Enterprise Value Multiple | -18.91 | -5.41 | -0.24 | 0.91 | -185.25 |
| Enterprise Value | 250.82M | 311.49M | 8.72M | -12.25M | 632.15M |
| EV to EBITDA | -18.91 | -5.41 | -0.24 | 0.91 | -185.25 |
| EV to Sales | 307.61 | 123.41 | 149.13 | 0.00 | 0.00 |
| EV to Free Cash Flow | -25.92 | -29.60 | -0.64 | 1.41 | -308.94 |
| EV to Operating Cash Flow | -25.92 | -29.68 | -0.64 | 1.41 | -309.23 |
| Tangible Book Value Per Share | -8.48 | -154.25 | -15835.17 | 6203.38 | 445.24 |
| Shareholders’ Equity Per Share | 48.03 | 85.01 | -1113.28 | 6203.38 | 445.24 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.02 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 2.48 | 22.33 | 11.62 | 0.00 | 0.00 |
| Net Income Per Share | -42.76 | -519.16 | -7434.36 | -3718.43 | -1051.81 |
| Tax Burden | 1.00 | 0.98 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.06 | 1.02 | 1.02 | 1.00 | 1.00 |
| Research & Development to Revenue | -0.08 | 0.06 | 33.34 | 0.00 | 0.00 |
| SG&A to Revenue | 8.64 | 4.45 | 252.64 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.09 | 0.17 | 5.64 | 0.00 | 0.00 |
| Income Quality | 0.69 | 0.18 | 0.36 | 0.65 | 0.60 |
Currency in USD
